Form 4: Medtronic Director Kevin E. Lofton Reports Stock Transaction
SEC Form 4 Filing
Kevin E. Lofton, a director at Medtronic plc, reported a transaction involving ordinary shares on May 1, 2024.
Summary
- On May 1, 2024, Kevin E. Lofton, a director of Medtronic plc, reported a transaction involving the company's ordinary shares.
- A total of 192 shares were disposed of at a price of $80.89 per share to cover tax obligations related to the vesting of restricted stock units.
- Following the transaction, Lofton directly owns 6,230 ordinary shares of Medtronic plc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It is a common practice for executives to sell shares to cover tax obligations when restricted stock units vest.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale of shares by a director to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of the stock transaction (disposal of shares). |
| 05/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.